Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Hepatitis B Vaccine in Bone Marrow Transplant Patients
IRCT20140818018842N45Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Tehran University of Medical Sciences. Primary endpoint: Immune response to hepatitis B vaccine. Started Feb 2025; status: recruiting.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on IRCT20140818018842N45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140818018842N45.